In 2018, Elastagen was acquired by global biopharma Allergan, in a deal totalling AU $400 million (US $265 million) with further milestone payments to come.
The Company’s lead program targets the development of an injectable product for tissue augmentation.
Brandon Capital is aware of scammers impersonating us - offering jobs and asking for bank details. We do not offer employment or ask for banking details via SMS, websites or phone calls. Do not provide any details and report to the relevant authorities in your location.
